(19) |
 |
|
(11) |
EP 4 356 906 A8 |
(12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
(15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
(48) |
Corrigendum issued on: |
|
03.07.2024 Bulletin 2024/27 |
(43) |
Date of publication: |
|
24.04.2024 Bulletin 2024/17 |
(22) |
Date of filing: 19.10.2023 |
|
(51) |
International Patent Classification (IPC):
|
|
(84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
KH MA MD TN |
(30) |
Priority: |
20.10.2022 IT 202200021624
|
(71) |
Applicant: SIFI S.p.A. |
|
95025 Aci Sant'Antonio (CT) (IT) |
|
(72) |
Inventors: |
|
- LA ROSA, Luca Rosario
95045 Misterbianco (IT)
- PEPE, Veronica
95030 Mascalucia (IT)
- ZAPPULLA, Cristina Maria Concetta
95127 Catania (IT)
|
(74) |
Representative: Cattaneo, Elisabetta et al |
|
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30 20149 Milano 20149 Milano (IT) |
|
|
|
(54) |
NUTRACEUTICAL COMPOSITION WITH NEUROPROTECTIVE EFFECT FOR THE TREATMENT OF GLAUCOMA |
(57) The present invention concerns a nutraceutical composition with a neuroprotective
effect for the treatment of glaucoma, comprising riboflavin, epigallocatechin gallate,
citicoline, forskolin, and homotaurine.